• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水飞蓟宾在非酒精性脂肪性肝炎的体外模型中调节胶原代谢。

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH.

机构信息

Fondazione Italiana Fegato, ONLUS, AREA Science Park Basovizza SS 14 km 163.5, 34149 Trieste, Italy.

出版信息

Molecules. 2019 Apr 2;24(7):1280. doi: 10.3390/molecules24071280.

DOI:10.3390/molecules24071280
PMID:30986937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6479571/
Abstract

Silybin has been proposed as a treatment for nonalcoholic steatohepatitis (NASH). In this study, we assessed the effect of Silybin in a well-established in vitro coculture model of early-stage NASH. LX2 and Huh7 cells were exposed to free fatty acid (FFA) and Silybin as mono- or coculture (SCC). Cell viability, LX2 activation, collagen deposition, metalloproteinase 2 and 9 (MMP2-9) activity, and ROS generation were determined at 24, 96, and 144 h. Exposure to FFA induced the activation of LX2 as shown by the increase in cell viability and upregulation of collagen biosynthesis. Interestingly, while cotreatment with Silybin did not affect collagen production in LX2, a significant reduction was observed in SCC. MMP2-9 activity was reduced in FFA-treated Huh7 and SCC and cotreatment with Silybin induced a dose-dependent increase, while no effect was observed in LX2. Silybin also showed antioxidant properties by reducing the FFA-induced production of ROS in all the cell systems. Based on these data, Silybin exerts its beneficial effects by reducing LX2 proliferation and ROS generation. Moreover, MMP2-9 modulation in hepatocytes represents the driving mechanism for the net reduction of collagen in this NASH in vitro model, highlighting the importance of hepatic cells interplay in NASH development and resolution.

摘要

水飞蓟宾被提议用于治疗非酒精性脂肪性肝炎(NASH)。在这项研究中,我们评估了水飞蓟宾在一个成熟的体外 NASH 早期共培养模型中的作用。LX2 和 Huh7 细胞暴露于游离脂肪酸(FFA)和水飞蓟宾的单一或共培养(SCC)中。在 24、96 和 144 小时时测定细胞活力、LX2 激活、胶原沉积、金属蛋白酶 2 和 9(MMP2-9)活性和 ROS 生成。FFA 的暴露如通过细胞活力的增加和胶原生物合成的上调所示诱导 LX2 的激活。有趣的是,虽然水飞蓟宾的共同处理并没有影响 LX2 中的胶原产生,但在 SCC 中观察到显著减少。MMP2-9 活性在 FFA 处理的 Huh7 和 SCC 中降低,并且与水飞蓟宾的共同处理诱导剂量依赖性增加,而在 LX2 中没有观察到。水飞蓟宾还通过减少所有细胞系统中 FFA 诱导的 ROS 产生表现出抗氧化特性。基于这些数据,水飞蓟宾通过减少 LX2 的增殖和 ROS 的产生发挥其有益作用。此外,肝细胞中 MMP2-9 的调节代表了这种 NASH 体外模型中胶原净减少的驱动机制,突出了肝细胞相互作用在 NASH 发展和解决中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/bad29651f6bb/molecules-24-01280-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/f52b999c20d7/molecules-24-01280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/52ea767b0239/molecules-24-01280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/1b5ea10d06d8/molecules-24-01280-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/c853fe5780e7/molecules-24-01280-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/bad29651f6bb/molecules-24-01280-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/f52b999c20d7/molecules-24-01280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/52ea767b0239/molecules-24-01280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/1b5ea10d06d8/molecules-24-01280-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/c853fe5780e7/molecules-24-01280-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7832/6479571/bad29651f6bb/molecules-24-01280-g005.jpg

相似文献

1
Silybin Modulates Collagen Turnover in an In Vitro Model of NASH.水飞蓟宾在非酒精性脂肪性肝炎的体外模型中调节胶原代谢。
Molecules. 2019 Apr 2;24(7):1280. doi: 10.3390/molecules24071280.
2
The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH.非酒精性脂肪性肝炎体外模型中肝星状细胞与肝细胞之间的相互作用。
Toxicol In Vitro. 2015 Oct;29(7):1753-8. doi: 10.1016/j.tiv.2015.07.010. Epub 2015 Jul 14.
3
Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model.奥贝胆酸和 INT-767 调节 NASH 体外模型中的胶原沉积。
Sci Rep. 2020 Feb 3;10(1):1699. doi: 10.1038/s41598-020-58562-x.
4
The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.脂肪堆积诱导的肝纤维化形成过程中,肝细胞与肝星状细胞相互作用的重要性。
Exp Mol Pathol. 2015 Feb;98(1):85-92. doi: 10.1016/j.yexmp.2014.12.006. Epub 2014 Dec 20.
5
Aquaporin-9 is involved in the lipid-lowering activity of the nutraceutical silybin on hepatocytes through modulation of autophagy and lipid droplets composition.水通道蛋白-9通过调节自噬和脂滴组成参与了营养保健品水飞蓟宾对肝细胞的降脂活性。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158586. doi: 10.1016/j.bbalip.2019.158586. Epub 2019 Dec 6.
6
The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH).熊果酸和毛蕊花糖苷在非酒精性脂肪性肝炎(NASH)体外模型中的有益作用
Int J Mol Sci. 2022 Mar 24;23(7):3562. doi: 10.3390/ijms23073562.
7
Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.水飞蓟宾通过抑制氧化应激和参与 NF-κB 通路缓解 NASH 小鼠的肝脂肪变性和纤维化。
Dig Dis Sci. 2018 Dec;63(12):3398-3408. doi: 10.1007/s10620-018-5268-0. Epub 2018 Sep 6.
8
Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin.过量的果糖和脂肪酸在体外引发非酒精性脂肪肝病进展模型:类黄酮水飞蓟宾的保护作用。
Int J Mol Med. 2019 Aug;44(2):705-712. doi: 10.3892/ijmm.2019.4234. Epub 2019 Jun 6.
9
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.在肝星状细胞系中暴露于人类免疫缺陷病毒/丙型肝炎病毒揭示了病毒与细胞类型之间协同的促纤维化转录激活作用。
Hepatology. 2016 Dec;64(6):1951-1968. doi: 10.1002/hep.28766. Epub 2016 Oct 5.
10
Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.有氧运动训练用于治疗非酒精性脂肪性肝病相关纤维化
J Physiol. 2016 Sep 15;594(18):5271-84. doi: 10.1113/JP272235. Epub 2016 May 27.

引用本文的文献

1
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders.新型策略增强水飞蓟宾生物利用度及其治疗肝脏疾病的治疗潜力。
Drug Des Devel Ther. 2024 Oct 19;18:4629-4659. doi: 10.2147/DDDT.S483140. eCollection 2024.
2
Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action.营养保健品对肝星状细胞激活的抑制作用:重点关注作用机制。
J Food Sci Technol. 2024 Nov;61(11):2046-2056. doi: 10.1007/s13197-024-06002-3. Epub 2024 May 18.
3
Evaluation of Silybin Nanoparticles against Liver Damage in Murine Infection.

本文引用的文献

1
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的全球流行病学:我们未来的需求。
Liver Int. 2018 Feb;38 Suppl 1:47-51. doi: 10.1111/liv.13643.
2
The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials.水飞蓟素治疗非酒精性脂肪性疾病的疗效:随机对照试验的荟萃分析(PRISMA)
Medicine (Baltimore). 2017 Dec;96(49):e9061. doi: 10.1097/MD.0000000000009061.
3
Matrix Metalloproteinases (MMPs) in Liver Diseases.
水飞蓟宾纳米颗粒对小鼠感染性肝损伤的评估
Pharmaceutics. 2024 May 4;16(5):618. doi: 10.3390/pharmaceutics16050618.
4
Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases.慢性肝病发生发展中与线粒体功能障碍相关的机制
Biology (Basel). 2023 Oct 5;12(10):1311. doi: 10.3390/biology12101311.
5
The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH).熊果酸和毛蕊花糖苷在非酒精性脂肪性肝炎(NASH)体外模型中的有益作用
Int J Mol Sci. 2022 Mar 24;23(7):3562. doi: 10.3390/ijms23073562.
6
Silymarin and Derivatives: From Biosynthesis to Health Benefits.水飞蓟素及其衍生物:从生物合成到健康益处。
Molecules. 2020 May 22;25(10):2415. doi: 10.3390/molecules25102415.
7
Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells.磷脂-药物制剂的协同作用显著使促纤维化的人肝星状细胞失活。
Pharmaceutics. 2019 Dec 12;11(12):676. doi: 10.3390/pharmaceutics11120676.
肝脏疾病中的基质金属蛋白酶(MMPs)
J Clin Exp Hepatol. 2017 Dec;7(4):367-372. doi: 10.1016/j.jceh.2017.09.004. Epub 2017 Oct 3.
4
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
5
Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.水飞蓟素对非酒精性脂肪性肝炎幼鼠模型的口服给药作用。
Nutrients. 2017 Sep 12;9(9):1006. doi: 10.3390/nu9091006.
6
Mechanisms of hepatic stellate cell activation.肝星状细胞激活的机制。
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411. doi: 10.1038/nrgastro.2017.38. Epub 2017 May 10.
7
Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.肝纤维化:理解双向伤口修复动力学以指导标志物和治疗方法的设计
Dig Dis. 2017;35(4):310-313. doi: 10.1159/000456581. Epub 2017 May 3.
8
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.水飞蓟宾治疗非酒精性脂肪性肝炎的随机试验。
Clin Gastroenterol Hepatol. 2017 Dec;15(12):1940-1949.e8. doi: 10.1016/j.cgh.2017.04.016. Epub 2017 Apr 15.
9
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.水飞蓟素/水飞蓟宾与慢性肝病:多年的结合
Molecules. 2017 Jan 24;22(2):191. doi: 10.3390/molecules22020191.
10
Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression.水飞蓟宾通过增强p53/p27并抑制Akt下游信号蛋白表达诱导肝星状细胞周期停滞。
Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):80-87. doi: 10.1016/s1499-3872(16)60166-2.